nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Parkinson's disease—Bromocriptine—type 2 diabetes mellitus	0.642	1	CpDpCtD
Gabapentin—ADORA1—nerve—type 2 diabetes mellitus	0.00288	0.157	CbGeAlD
Gabapentin—BCAT1—islet of Langerhans—type 2 diabetes mellitus	0.00219	0.119	CbGeAlD
Gabapentin—CACNA2D2—islet of Langerhans—type 2 diabetes mellitus	0.00201	0.109	CbGeAlD
Gabapentin—BCAT1—retina—type 2 diabetes mellitus	0.00187	0.102	CbGeAlD
Gabapentin—BCAT1—pancreas—type 2 diabetes mellitus	0.00154	0.0839	CbGeAlD
Gabapentin—BCAT1—adipose tissue—type 2 diabetes mellitus	0.0014	0.0762	CbGeAlD
Gabapentin—CACNA2D1—cardiovascular system—type 2 diabetes mellitus	0.00105	0.057	CbGeAlD
Gabapentin—ADORA1—cardiovascular system—type 2 diabetes mellitus	0.00101	0.0549	CbGeAlD
Gabapentin—ADORA1—kidney—type 2 diabetes mellitus	0.000986	0.0538	CbGeAlD
Gabapentin—ADORA1—cortex of kidney—type 2 diabetes mellitus	0.000961	0.0524	CbGeAlD
Gabapentin—CACNA2D1—adipose tissue—type 2 diabetes mellitus	0.000922	0.0502	CbGeAlD
Gabapentin—ADORA1—adipose tissue—type 2 diabetes mellitus	0.000889	0.0485	CbGeAlD
Gabapentin—CACNA2D1—liver—type 2 diabetes mellitus	0.000646	0.0352	CbGeAlD
Gabapentin—CACNA2D2—Metabolism—ABCC8—type 2 diabetes mellitus	8.9e-05	0.00107	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CBS—type 2 diabetes mellitus	8.9e-05	0.00107	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CETP—type 2 diabetes mellitus	8.9e-05	0.00107	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GIP—type 2 diabetes mellitus	8.61e-05	0.00103	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—COX2—type 2 diabetes mellitus	8.57e-05	0.00103	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC5A2—type 2 diabetes mellitus	8.57e-05	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GCG—type 2 diabetes mellitus	8.51e-05	0.00102	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NCOA6—type 2 diabetes mellitus	8.42e-05	0.00101	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HSD11B1—type 2 diabetes mellitus	8.28e-05	0.000995	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—UCP2—type 2 diabetes mellitus	8.28e-05	0.000995	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—UCP3—type 2 diabetes mellitus	8.28e-05	0.000995	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SREBF1—type 2 diabetes mellitus	8.28e-05	0.000995	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PSMD6—type 2 diabetes mellitus	8.28e-05	0.000995	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SNAP25—type 2 diabetes mellitus	8.28e-05	0.000995	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—SERPINE1—type 2 diabetes mellitus	8.22e-05	0.000988	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CTGF—type 2 diabetes mellitus	8.12e-05	0.000977	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	8.08e-05	0.000971	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	8.06e-05	0.000969	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HMGCR—type 2 diabetes mellitus	8.05e-05	0.000968	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	7.9e-05	0.000949	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ADRA2A—type 2 diabetes mellitus	7.88e-05	0.000947	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	7.79e-05	0.000936	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PCK1—type 2 diabetes mellitus	7.78e-05	0.000936	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP2E1—type 2 diabetes mellitus	7.57e-05	0.00091	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	7.5e-05	0.000902	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP1A2—type 2 diabetes mellitus	7.49e-05	0.0009	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SLC2A1—type 2 diabetes mellitus	7.49e-05	0.0009	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	7.34e-05	0.000882	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	7.32e-05	0.00088	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.3e-05	0.000878	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HK1—type 2 diabetes mellitus	7.29e-05	0.000876	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	7.27e-05	0.000874	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—AVP—type 2 diabetes mellitus	7.24e-05	0.00087	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.18e-05	0.000863	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GCG—type 2 diabetes mellitus	7.18e-05	0.000863	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	7.12e-05	0.000856	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	7.07e-05	0.00085	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—KCNJ11—type 2 diabetes mellitus	7.04e-05	0.000846	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HSD3B2—type 2 diabetes mellitus	7.04e-05	0.000846	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GCKR—type 2 diabetes mellitus	7.04e-05	0.000846	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LPA—type 2 diabetes mellitus	7.04e-05	0.000846	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	6.94e-05	0.000834	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	6.88e-05	0.000827	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	6.83e-05	0.000821	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALDOB—type 2 diabetes mellitus	6.75e-05	0.000811	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	6.47e-05	0.000777	CbGpPWpGaD
Gabapentin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.35e-05	0.000248	CcSEcCtD
Gabapentin—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.35e-05	0.000248	CcSEcCtD
Gabapentin—Vertigo—Losartan—type 2 diabetes mellitus	6.34e-05	0.000247	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.34e-05	0.000247	CcSEcCtD
Gabapentin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.33e-05	0.000247	CcSEcCtD
Gabapentin—Somnolence—Valsartan—type 2 diabetes mellitus	6.33e-05	0.000247	CcSEcCtD
Gabapentin—Syncope—Losartan—type 2 diabetes mellitus	6.32e-05	0.000247	CcSEcCtD
Gabapentin—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.32e-05	0.000246	CcSEcCtD
Gabapentin—Leukopenia—Losartan—type 2 diabetes mellitus	6.31e-05	0.000246	CcSEcCtD
Gabapentin—Discomfort—Irbesartan—type 2 diabetes mellitus	6.3e-05	0.000246	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	6.3e-05	0.000758	CbGpPWpGaD
Gabapentin—Skin disorder—Metformin—type 2 diabetes mellitus	6.3e-05	0.000246	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—GCGR—type 2 diabetes mellitus	6.28e-05	0.000755	CbGpPWpGaD
Gabapentin—Immune system disorder—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000245	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GLP1R—type 2 diabetes mellitus	6.27e-05	0.000754	CbGpPWpGaD
Gabapentin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.27e-05	0.000244	CcSEcCtD
Gabapentin—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.27e-05	0.000244	CcSEcCtD
Gabapentin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000244	CcSEcCtD
Gabapentin—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.24e-05	0.000243	CcSEcCtD
Gabapentin—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.24e-05	0.000243	CcSEcCtD
Gabapentin—Palpitations—Losartan—type 2 diabetes mellitus	6.23e-05	0.000243	CcSEcCtD
Gabapentin—Nausea—Glimepiride—type 2 diabetes mellitus	6.21e-05	0.000242	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	6.2e-05	0.000745	CbGpPWpGaD
Gabapentin—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.2e-05	0.000242	CcSEcCtD
Gabapentin—Nausea—Sitagliptin—type 2 diabetes mellitus	6.19e-05	0.000242	CcSEcCtD
Gabapentin—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.19e-05	0.000242	CcSEcCtD
Gabapentin—Asthenia—Glyburide—type 2 diabetes mellitus	6.19e-05	0.000241	CcSEcCtD
Gabapentin—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.19e-05	0.000241	CcSEcCtD
Gabapentin—BCAT1—Metabolism—GNB3—type 2 diabetes mellitus	6.19e-05	0.000744	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.19e-05	0.000744	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	6.18e-05	0.000743	CbGpPWpGaD
Gabapentin—Anorexia—Metformin—type 2 diabetes mellitus	6.18e-05	0.000241	CcSEcCtD
Gabapentin—BCAT1—Metabolism—HMOX1—type 2 diabetes mellitus	6.16e-05	0.00074	CbGpPWpGaD
Gabapentin—Cough—Losartan—type 2 diabetes mellitus	6.15e-05	0.00024	CcSEcCtD
Gabapentin—Urticaria—Gliclazide—type 2 diabetes mellitus	6.15e-05	0.00024	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	6.15e-05	0.00074	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	6.15e-05	0.000739	CbGpPWpGaD
Gabapentin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.14e-05	0.00024	CcSEcCtD
Gabapentin—Alopecia—Ramipril—type 2 diabetes mellitus	6.14e-05	0.00024	CcSEcCtD
Gabapentin—Fatigue—Valsartan—type 2 diabetes mellitus	6.14e-05	0.000239	CcSEcCtD
Gabapentin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.12e-05	0.000239	CcSEcCtD
Gabapentin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.12e-05	0.000239	CcSEcCtD
Gabapentin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.000239	CcSEcCtD
Gabapentin—Oedema—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.000239	CcSEcCtD
Gabapentin—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.11e-05	0.000239	CcSEcCtD
Gabapentin—Pruritus—Glyburide—type 2 diabetes mellitus	6.1e-05	0.000238	CcSEcCtD
Gabapentin—Mental disorder—Ramipril—type 2 diabetes mellitus	6.09e-05	0.000237	CcSEcCtD
Gabapentin—Constipation—Valsartan—type 2 diabetes mellitus	6.09e-05	0.000237	CcSEcCtD
Gabapentin—Infection—Irbesartan—type 2 diabetes mellitus	6.08e-05	0.000237	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CAT—type 2 diabetes mellitus	6.08e-05	0.00073	CbGpPWpGaD
Gabapentin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.07e-05	0.000237	CcSEcCtD
Gabapentin—Fatigue—Orlistat—type 2 diabetes mellitus	6.06e-05	0.000237	CcSEcCtD
Gabapentin—Hypotension—Metformin—type 2 diabetes mellitus	6.06e-05	0.000236	CcSEcCtD
Gabapentin—Malnutrition—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000236	CcSEcCtD
Gabapentin—Erythema—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000236	CcSEcCtD
Gabapentin—Shock—Irbesartan—type 2 diabetes mellitus	6.02e-05	0.000235	CcSEcCtD
Gabapentin—Pain—Orlistat—type 2 diabetes mellitus	6.01e-05	0.000235	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—C3—type 2 diabetes mellitus	6.01e-05	0.000723	CbGpPWpGaD
Gabapentin—Chest pain—Losartan—type 2 diabetes mellitus	6e-05	0.000234	CcSEcCtD
Gabapentin—Arthralgia—Losartan—type 2 diabetes mellitus	6e-05	0.000234	CcSEcCtD
Gabapentin—Myalgia—Losartan—type 2 diabetes mellitus	6e-05	0.000234	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	6e-05	0.000721	CbGpPWpGaD
Gabapentin—Vomiting—Bromocriptine—type 2 diabetes mellitus	6e-05	0.000234	CcSEcCtD
Gabapentin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	6e-05	0.000234	CcSEcCtD
Gabapentin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.99e-05	0.000234	CcSEcCtD
Gabapentin—Anxiety—Losartan—type 2 diabetes mellitus	5.98e-05	0.000233	CcSEcCtD
Gabapentin—Tachycardia—Irbesartan—type 2 diabetes mellitus	5.97e-05	0.000233	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	5.97e-05	0.000717	CbGpPWpGaD
Gabapentin—Rash—Bromocriptine—type 2 diabetes mellitus	5.95e-05	0.000232	CcSEcCtD
Gabapentin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.94e-05	0.000232	CcSEcCtD
Gabapentin—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.94e-05	0.000232	CcSEcCtD
Gabapentin—Tension—Ramipril—type 2 diabetes mellitus	5.93e-05	0.000232	CcSEcCtD
Gabapentin—Discomfort—Losartan—type 2 diabetes mellitus	5.93e-05	0.000231	CcSEcCtD
Gabapentin—Dysgeusia—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000231	CcSEcCtD
Gabapentin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.91e-05	0.000231	CcSEcCtD
Gabapentin—Headache—Bromocriptine—type 2 diabetes mellitus	5.91e-05	0.000231	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.9e-05	0.00023	CcSEcCtD
Gabapentin—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.9e-05	0.00023	CcSEcCtD
Gabapentin—BCAT1—Metabolism—APOB—type 2 diabetes mellitus	5.9e-05	0.000709	CbGpPWpGaD
Gabapentin—Nervousness—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000229	CcSEcCtD
Gabapentin—Dry mouth—Losartan—type 2 diabetes mellitus	5.87e-05	0.000229	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—SLC2A2—type 2 diabetes mellitus	5.86e-05	0.000704	CbGpPWpGaD
Gabapentin—Anorexia—Irbesartan—type 2 diabetes mellitus	5.83e-05	0.000227	CcSEcCtD
Gabapentin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.82e-05	0.000227	CcSEcCtD
Gabapentin—Paraesthesia—Metformin—type 2 diabetes mellitus	5.82e-05	0.000227	CcSEcCtD
Gabapentin—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.81e-05	0.000227	CcSEcCtD
Gabapentin—Confusional state—Losartan—type 2 diabetes mellitus	5.8e-05	0.000226	CcSEcCtD
Gabapentin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.8e-05	0.000226	CcSEcCtD
Gabapentin—Dyspnoea—Metformin—type 2 diabetes mellitus	5.78e-05	0.000225	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—GRK5—type 2 diabetes mellitus	5.78e-05	0.000694	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GIPR—type 2 diabetes mellitus	5.78e-05	0.000694	CbGpPWpGaD
Gabapentin—Somnolence—Metformin—type 2 diabetes mellitus	5.76e-05	0.000225	CcSEcCtD
Gabapentin—Oedema—Losartan—type 2 diabetes mellitus	5.76e-05	0.000225	CcSEcCtD
Gabapentin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.76e-05	0.000225	CcSEcCtD
Gabapentin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.75e-05	0.000224	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CPT1A—type 2 diabetes mellitus	5.74e-05	0.00069	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTR—type 2 diabetes mellitus	5.74e-05	0.00069	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTM1—type 2 diabetes mellitus	5.74e-05	0.00069	CbGpPWpGaD
Gabapentin—Infection—Losartan—type 2 diabetes mellitus	5.72e-05	0.000223	CcSEcCtD
Gabapentin—Hypotension—Irbesartan—type 2 diabetes mellitus	5.72e-05	0.000223	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	5.71e-05	0.000687	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—AGT—type 2 diabetes mellitus	5.71e-05	0.000687	CbGpPWpGaD
Gabapentin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.71e-05	0.000223	CcSEcCtD
Gabapentin—Dyspepsia—Metformin—type 2 diabetes mellitus	5.71e-05	0.000223	CcSEcCtD
Gabapentin—Tremor—Ramipril—type 2 diabetes mellitus	5.67e-05	0.000221	CcSEcCtD
Gabapentin—Shock—Losartan—type 2 diabetes mellitus	5.66e-05	0.000221	CcSEcCtD
Gabapentin—Urticaria—Valsartan—type 2 diabetes mellitus	5.65e-05	0.000221	CcSEcCtD
Gabapentin—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.64e-05	0.00022	CcSEcCtD
Gabapentin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.64e-05	0.00022	CcSEcCtD
Gabapentin—Decreased appetite—Metformin—type 2 diabetes mellitus	5.63e-05	0.00022	CcSEcCtD
Gabapentin—BCAT1—Metabolism—LPL—type 2 diabetes mellitus	5.63e-05	0.000677	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NAMPT—type 2 diabetes mellitus	5.63e-05	0.000676	CbGpPWpGaD
Gabapentin—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.63e-05	0.00022	CcSEcCtD
Gabapentin—Tachycardia—Losartan—type 2 diabetes mellitus	5.62e-05	0.000219	CcSEcCtD
Gabapentin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.61e-05	0.000219	CcSEcCtD
Gabapentin—Nausea—Bromocriptine—type 2 diabetes mellitus	5.61e-05	0.000219	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.6e-05	0.000218	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—LIPC—type 2 diabetes mellitus	5.59e-05	0.000672	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GCK—type 2 diabetes mellitus	5.59e-05	0.000672	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HBA1—type 2 diabetes mellitus	5.59e-05	0.000672	CbGpPWpGaD
Gabapentin—Fatigue—Metformin—type 2 diabetes mellitus	5.59e-05	0.000218	CcSEcCtD
Gabapentin—Urticaria—Orlistat—type 2 diabetes mellitus	5.59e-05	0.000218	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	5.58e-05	0.000671	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.57e-05	0.000217	CcSEcCtD
Gabapentin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.56e-05	0.000217	CcSEcCtD
Gabapentin—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.56e-05	0.000217	CcSEcCtD
Gabapentin—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.56e-05	0.000217	CcSEcCtD
Gabapentin—Asthenia—Gliclazide—type 2 diabetes mellitus	5.56e-05	0.000217	CcSEcCtD
Gabapentin—Agitation—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000217	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CYP11A1—type 2 diabetes mellitus	5.56e-05	0.000668	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	5.55e-05	0.000667	CbGpPWpGaD
Gabapentin—Constipation—Metformin—type 2 diabetes mellitus	5.54e-05	0.000216	CcSEcCtD
Gabapentin—Angioedema—Ramipril—type 2 diabetes mellitus	5.53e-05	0.000216	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ADCY5—type 2 diabetes mellitus	5.51e-05	0.000663	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GPX1—type 2 diabetes mellitus	5.49e-05	0.000661	CbGpPWpGaD
Gabapentin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.49e-05	0.000214	CcSEcCtD
Gabapentin—Anorexia—Losartan—type 2 diabetes mellitus	5.49e-05	0.000214	CcSEcCtD
Gabapentin—Vomiting—Glyburide—type 2 diabetes mellitus	5.49e-05	0.000214	CcSEcCtD
Gabapentin—Pruritus—Gliclazide—type 2 diabetes mellitus	5.48e-05	0.000214	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—SLC9A1—type 2 diabetes mellitus	5.46e-05	0.000656	CbGpPWpGaD
Gabapentin—Malaise—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000213	CcSEcCtD
Gabapentin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.45e-05	0.000213	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	5.45e-05	0.000655	CbGpPWpGaD
Gabapentin—Rash—Glyburide—type 2 diabetes mellitus	5.44e-05	0.000212	CcSEcCtD
Gabapentin—Somnolence—Irbesartan—type 2 diabetes mellitus	5.44e-05	0.000212	CcSEcCtD
Gabapentin—Dermatitis—Glyburide—type 2 diabetes mellitus	5.43e-05	0.000212	CcSEcCtD
Gabapentin—Vertigo—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000212	CcSEcCtD
Gabapentin—Syncope—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000212	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	5.42e-05	0.000651	CbGpPWpGaD
Gabapentin—Leukopenia—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000211	CcSEcCtD
Gabapentin—Headache—Glyburide—type 2 diabetes mellitus	5.4e-05	0.000211	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	5.4e-05	0.000649	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CETP—type 2 diabetes mellitus	5.39e-05	0.000648	CbGpPWpGaD
Gabapentin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.38e-05	0.00021	CcSEcCtD
Gabapentin—Hypotension—Losartan—type 2 diabetes mellitus	5.38e-05	0.00021	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CD36—type 2 diabetes mellitus	5.35e-05	0.000643	CbGpPWpGaD
Gabapentin—Palpitations—Ramipril—type 2 diabetes mellitus	5.34e-05	0.000209	CcSEcCtD
Gabapentin—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.34e-05	0.000208	CcSEcCtD
Gabapentin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.32e-05	0.000207	CcSEcCtD
Gabapentin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000207	CcSEcCtD
Gabapentin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.3e-05	0.000207	CcSEcCtD
Gabapentin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.3e-05	0.000207	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.28e-05	0.000635	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MC4R—type 2 diabetes mellitus	5.28e-05	0.000635	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	5.28e-05	0.000635	CbGpPWpGaD
Gabapentin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000206	CcSEcCtD
Gabapentin—Cough—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000206	CcSEcCtD
Gabapentin—Fatigue—Irbesartan—type 2 diabetes mellitus	5.27e-05	0.000206	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	5.26e-05	0.000632	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.24e-05	0.000205	CcSEcCtD
Gabapentin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.24e-05	0.000205	CcSEcCtD
Gabapentin—Convulsion—Ramipril—type 2 diabetes mellitus	5.24e-05	0.000204	CcSEcCtD
Gabapentin—Pain—Irbesartan—type 2 diabetes mellitus	5.23e-05	0.000204	CcSEcCtD
Gabapentin—Constipation—Irbesartan—type 2 diabetes mellitus	5.23e-05	0.000204	CcSEcCtD
Gabapentin—Insomnia—Losartan—type 2 diabetes mellitus	5.21e-05	0.000203	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	5.19e-05	0.000624	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	5.19e-05	0.000624	CbGpPWpGaD
Gabapentin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.18e-05	0.000202	CcSEcCtD
Gabapentin—Paraesthesia—Losartan—type 2 diabetes mellitus	5.17e-05	0.000202	CcSEcCtD
Gabapentin—Urticaria—Metformin—type 2 diabetes mellitus	5.15e-05	0.000201	CcSEcCtD
Gabapentin—Myalgia—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000201	CcSEcCtD
Gabapentin—Chest pain—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000201	CcSEcCtD
Gabapentin—Arthralgia—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000201	CcSEcCtD
Gabapentin—Dyspnoea—Losartan—type 2 diabetes mellitus	5.13e-05	0.0002	CcSEcCtD
Gabapentin—Anxiety—Ramipril—type 2 diabetes mellitus	5.13e-05	0.0002	CcSEcCtD
Gabapentin—Nausea—Glyburide—type 2 diabetes mellitus	5.12e-05	0.0002	CcSEcCtD
Gabapentin—Abdominal pain—Metformin—type 2 diabetes mellitus	5.12e-05	0.0002	CcSEcCtD
Gabapentin—Dizziness—Gliclazide—type 2 diabetes mellitus	5.12e-05	0.0002	CcSEcCtD
Gabapentin—Somnolence—Losartan—type 2 diabetes mellitus	5.12e-05	0.0002	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.11e-05	0.000199	CcSEcCtD
Gabapentin—Asthenia—Valsartan—type 2 diabetes mellitus	5.11e-05	0.000199	CcSEcCtD
Gabapentin—Discomfort—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000198	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—GIP—type 2 diabetes mellitus	5.09e-05	0.000611	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MTHFR—type 2 diabetes mellitus	5.07e-05	0.00061	CbGpPWpGaD
Gabapentin—Dyspepsia—Losartan—type 2 diabetes mellitus	5.07e-05	0.000198	CcSEcCtD
Gabapentin—Asthenia—Orlistat—type 2 diabetes mellitus	5.05e-05	0.000197	CcSEcCtD
Gabapentin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.000197	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	5.04e-05	0.000606	CbGpPWpGaD
Gabapentin—Pruritus—Valsartan—type 2 diabetes mellitus	5.04e-05	0.000196	CcSEcCtD
Gabapentin—Dry mouth—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000196	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—PSMD6—type 2 diabetes mellitus	5.01e-05	0.000603	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SREBF1—type 2 diabetes mellitus	5.01e-05	0.000603	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SNAP25—type 2 diabetes mellitus	5.01e-05	0.000603	CbGpPWpGaD
Gabapentin—Decreased appetite—Losartan—type 2 diabetes mellitus	5e-05	0.000195	CcSEcCtD
Gabapentin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5e-05	0.000195	CcSEcCtD
Gabapentin—Confusional state—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000194	CcSEcCtD
Gabapentin—Pruritus—Orlistat—type 2 diabetes mellitus	4.98e-05	0.000194	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PPARA—type 2 diabetes mellitus	4.97e-05	0.000598	CbGpPWpGaD
Gabapentin—Fatigue—Losartan—type 2 diabetes mellitus	4.96e-05	0.000194	CcSEcCtD
Gabapentin—Oedema—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000193	CcSEcCtD
Gabapentin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000193	CcSEcCtD
Gabapentin—Vomiting—Gliclazide—type 2 diabetes mellitus	4.93e-05	0.000192	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CTGF—type 2 diabetes mellitus	4.92e-05	0.000592	CbGpPWpGaD
Gabapentin—Pain—Losartan—type 2 diabetes mellitus	4.92e-05	0.000192	CcSEcCtD
Gabapentin—Constipation—Losartan—type 2 diabetes mellitus	4.92e-05	0.000192	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	4.9e-05	0.000589	CbGpPWpGaD
Gabapentin—Rash—Gliclazide—type 2 diabetes mellitus	4.88e-05	0.000191	CcSEcCtD
Gabapentin—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.88e-05	0.00019	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—HMGCR—type 2 diabetes mellitus	4.88e-05	0.000586	CbGpPWpGaD
Gabapentin—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.87e-05	0.00019	CcSEcCtD
Gabapentin—Urticaria—Irbesartan—type 2 diabetes mellitus	4.86e-05	0.00019	CcSEcCtD
Gabapentin—Shock—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000189	CcSEcCtD
Gabapentin—Headache—Gliclazide—type 2 diabetes mellitus	4.85e-05	0.000189	CcSEcCtD
Gabapentin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.84e-05	0.000189	CcSEcCtD
Gabapentin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.84e-05	0.000189	CcSEcCtD
Gabapentin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.84e-05	0.000189	CcSEcCtD
Gabapentin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.83e-05	0.000189	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—LEPR—type 2 diabetes mellitus	4.83e-05	0.000581	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AGT—type 2 diabetes mellitus	4.82e-05	0.000579	CbGpPWpGaD
Gabapentin—Tachycardia—Ramipril—type 2 diabetes mellitus	4.82e-05	0.000188	CcSEcCtD
Gabapentin—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.81e-05	0.000188	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	4.81e-05	0.000578	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	4.8e-05	0.000577	CbGpPWpGaD
Gabapentin—Skin disorder—Ramipril—type 2 diabetes mellitus	4.79e-05	0.000187	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	4.78e-05	0.000574	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ADRA2A—type 2 diabetes mellitus	4.77e-05	0.000574	CbGpPWpGaD
Gabapentin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000186	CcSEcCtD
Gabapentin—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.74e-05	0.000185	CcSEcCtD
Gabapentin—BCAT1—Metabolism—CALM1—type 2 diabetes mellitus	4.74e-05	0.000569	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	4.73e-05	0.000569	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOE—type 2 diabetes mellitus	4.72e-05	0.000567	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	4.72e-05	0.000567	CbGpPWpGaD
Gabapentin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.71e-05	0.000184	CcSEcCtD
Gabapentin—Dizziness—Valsartan—type 2 diabetes mellitus	4.71e-05	0.000184	CcSEcCtD
Gabapentin—ADORA1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	4.71e-05	0.000566	CbGpPWpGaD
Gabapentin—Anorexia—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000184	CcSEcCtD
Gabapentin—BCAT1—Metabolism—APOA1—type 2 diabetes mellitus	4.67e-05	0.000561	CbGpPWpGaD
Gabapentin—Dizziness—Orlistat—type 2 diabetes mellitus	4.65e-05	0.000181	CcSEcCtD
Gabapentin—Asthenia—Metformin—type 2 diabetes mellitus	4.65e-05	0.000181	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	4.62e-05	0.000555	CbGpPWpGaD
Gabapentin—Hypotension—Ramipril—type 2 diabetes mellitus	4.61e-05	0.00018	CcSEcCtD
Gabapentin—Nausea—Gliclazide—type 2 diabetes mellitus	4.6e-05	0.00018	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CYP2E1—type 2 diabetes mellitus	4.59e-05	0.000551	CbGpPWpGaD
Gabapentin—Pruritus—Metformin—type 2 diabetes mellitus	4.59e-05	0.000179	CcSEcCtD
Gabapentin—Urticaria—Losartan—type 2 diabetes mellitus	4.57e-05	0.000178	CcSEcCtD
Gabapentin—Abdominal pain—Losartan—type 2 diabetes mellitus	4.55e-05	0.000178	CcSEcCtD
Gabapentin—Body temperature increased—Losartan—type 2 diabetes mellitus	4.55e-05	0.000178	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CYP1A2—type 2 diabetes mellitus	4.54e-05	0.000545	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC2A1—type 2 diabetes mellitus	4.54e-05	0.000545	CbGpPWpGaD
Gabapentin—Vomiting—Valsartan—type 2 diabetes mellitus	4.53e-05	0.000177	CcSEcCtD
Gabapentin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.51e-05	0.000176	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000175	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—TLE4—type 2 diabetes mellitus	4.49e-05	0.00054	CbGpPWpGaD
Gabapentin—Rash—Valsartan—type 2 diabetes mellitus	4.49e-05	0.000175	CcSEcCtD
Gabapentin—Dermatitis—Valsartan—type 2 diabetes mellitus	4.48e-05	0.000175	CcSEcCtD
Gabapentin—Vomiting—Orlistat—type 2 diabetes mellitus	4.47e-05	0.000174	CcSEcCtD
Gabapentin—Insomnia—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000174	CcSEcCtD
Gabapentin—Headache—Valsartan—type 2 diabetes mellitus	4.46e-05	0.000174	CcSEcCtD
Gabapentin—Diarrhoea—Metformin—type 2 diabetes mellitus	4.43e-05	0.000173	CcSEcCtD
Gabapentin—Rash—Orlistat—type 2 diabetes mellitus	4.43e-05	0.000173	CcSEcCtD
Gabapentin—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000173	CcSEcCtD
Gabapentin—Dermatitis—Orlistat—type 2 diabetes mellitus	4.43e-05	0.000173	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.42e-05	0.000532	CbGpPWpGaD
Gabapentin—Headache—Orlistat—type 2 diabetes mellitus	4.41e-05	0.000172	CcSEcCtD
Gabapentin—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000172	CcSEcCtD
Gabapentin—Asthenia—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000171	CcSEcCtD
Gabapentin—Somnolence—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000171	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—GCG—type 2 diabetes mellitus	4.37e-05	0.000525	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.35e-05	0.000523	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GCG—type 2 diabetes mellitus	4.35e-05	0.000523	CbGpPWpGaD
Gabapentin—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.34e-05	0.00017	CcSEcCtD
Gabapentin—Pruritus—Irbesartan—type 2 diabetes mellitus	4.33e-05	0.000169	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	4.32e-05	0.00052	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	4.3e-05	0.000517	CbGpPWpGaD
Gabapentin—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000167	CcSEcCtD
Gabapentin—Dizziness—Metformin—type 2 diabetes mellitus	4.29e-05	0.000167	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000166	CcSEcCtD
Gabapentin—Fatigue—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000166	CcSEcCtD
Gabapentin—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.24e-05	0.000165	CcSEcCtD
Gabapentin—Nausea—Valsartan—type 2 diabetes mellitus	4.23e-05	0.000165	CcSEcCtD
Gabapentin—Constipation—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000165	CcSEcCtD
Gabapentin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.18e-05	0.000163	CcSEcCtD
Gabapentin—Nausea—Orlistat—type 2 diabetes mellitus	4.18e-05	0.000163	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	4.18e-05	0.000502	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	4.15e-05	0.000498	CbGpPWpGaD
Gabapentin—Asthenia—Losartan—type 2 diabetes mellitus	4.13e-05	0.000161	CcSEcCtD
Gabapentin—Vomiting—Metformin—type 2 diabetes mellitus	4.12e-05	0.000161	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PPARG—type 2 diabetes mellitus	4.11e-05	0.000494	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	4.09e-05	0.000492	CbGpPWpGaD
Gabapentin—Rash—Metformin—type 2 diabetes mellitus	4.09e-05	0.000159	CcSEcCtD
Gabapentin—Dermatitis—Metformin—type 2 diabetes mellitus	4.08e-05	0.000159	CcSEcCtD
Gabapentin—Pruritus—Losartan—type 2 diabetes mellitus	4.07e-05	0.000159	CcSEcCtD
Gabapentin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000159	CcSEcCtD
Gabapentin—Headache—Metformin—type 2 diabetes mellitus	4.06e-05	0.000158	CcSEcCtD
Gabapentin—Dizziness—Irbesartan—type 2 diabetes mellitus	4.04e-05	0.000158	CcSEcCtD
Gabapentin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000157	CcSEcCtD
Gabapentin—BCAT1—Metabolism—INS—type 2 diabetes mellitus	4.03e-05	0.000485	CbGpPWpGaD
Gabapentin—Diarrhoea—Losartan—type 2 diabetes mellitus	3.94e-05	0.000154	CcSEcCtD
Gabapentin—Urticaria—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000153	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—type 2 diabetes mellitus	3.91e-05	0.00047	CbGpPWpGaD
Gabapentin—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000152	CcSEcCtD
Gabapentin—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.9e-05	0.000152	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	3.89e-05	0.000468	CbGpPWpGaD
Gabapentin—Vomiting—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.000152	CcSEcCtD
Gabapentin—Rash—Irbesartan—type 2 diabetes mellitus	3.86e-05	0.00015	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	3.85e-05	0.000463	CbGpPWpGaD
Gabapentin—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.00015	CcSEcCtD
Gabapentin—Nausea—Metformin—type 2 diabetes mellitus	3.85e-05	0.00015	CcSEcCtD
Gabapentin—Headache—Irbesartan—type 2 diabetes mellitus	3.83e-05	0.000149	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	3.82e-05	0.000459	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	3.82e-05	0.000459	CbGpPWpGaD
Gabapentin—Dizziness—Losartan—type 2 diabetes mellitus	3.81e-05	0.000149	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	3.76e-05	0.000453	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.75e-05	0.000451	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GNB3—type 2 diabetes mellitus	3.75e-05	0.000451	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HMOX1—type 2 diabetes mellitus	3.73e-05	0.000448	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RBP4—type 2 diabetes mellitus	3.72e-05	0.000447	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	3.72e-05	0.000447	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AVP—type 2 diabetes mellitus	3.71e-05	0.000446	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	3.71e-05	0.000446	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALB—type 2 diabetes mellitus	3.7e-05	0.000444	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	3.69e-05	0.000444	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CAT—type 2 diabetes mellitus	3.68e-05	0.000443	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.66e-05	0.00044	CbGpPWpGaD
Gabapentin—Vomiting—Losartan—type 2 diabetes mellitus	3.66e-05	0.000143	CcSEcCtD
Gabapentin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000142	CcSEcCtD
Gabapentin—Nausea—Irbesartan—type 2 diabetes mellitus	3.63e-05	0.000142	CcSEcCtD
Gabapentin—Rash—Losartan—type 2 diabetes mellitus	3.63e-05	0.000142	CcSEcCtD
Gabapentin—Dermatitis—Losartan—type 2 diabetes mellitus	3.63e-05	0.000141	CcSEcCtD
Gabapentin—Headache—Losartan—type 2 diabetes mellitus	3.61e-05	0.000141	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—APOB—type 2 diabetes mellitus	3.57e-05	0.00043	CbGpPWpGaD
Gabapentin—Asthenia—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000138	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.54e-05	0.000425	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NOS3—type 2 diabetes mellitus	3.54e-05	0.000425	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	3.53e-05	0.000425	CbGpPWpGaD
Gabapentin—Pruritus—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000136	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	3.48e-05	0.000418	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTM1—type 2 diabetes mellitus	3.48e-05	0.000418	CbGpPWpGaD
Gabapentin—Nausea—Losartan—type 2 diabetes mellitus	3.42e-05	0.000133	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—LPL—type 2 diabetes mellitus	3.41e-05	0.00041	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—C3—type 2 diabetes mellitus	3.4e-05	0.000409	CbGpPWpGaD
Gabapentin—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000132	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	3.36e-05	0.000403	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ADCY5—type 2 diabetes mellitus	3.34e-05	0.000402	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GPX1—type 2 diabetes mellitus	3.33e-05	0.0004	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.32e-05	0.000399	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.3e-05	0.000396	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—INSR—type 2 diabetes mellitus	3.28e-05	0.000394	CbGpPWpGaD
Gabapentin—Dizziness—Ramipril—type 2 diabetes mellitus	3.26e-05	0.000127	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CD36—type 2 diabetes mellitus	3.24e-05	0.00039	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS2—type 2 diabetes mellitus	3.23e-05	0.000389	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.23e-05	0.000388	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.22e-05	0.000387	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.22e-05	0.000387	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.2e-05	0.000385	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.2e-05	0.000385	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.16e-05	0.00038	CbGpPWpGaD
Gabapentin—Vomiting—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000122	CcSEcCtD
Gabapentin—Rash—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000121	CcSEcCtD
Gabapentin—Dermatitis—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000121	CcSEcCtD
Gabapentin—Headache—Ramipril—type 2 diabetes mellitus	3.09e-05	0.000121	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—C3—type 2 diabetes mellitus	3.09e-05	0.000371	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTHFR—type 2 diabetes mellitus	3.07e-05	0.000369	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.07e-05	0.000369	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARA—type 2 diabetes mellitus	3.01e-05	0.000362	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.98e-05	0.000359	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.98e-05	0.000358	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.98e-05	0.000358	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.93e-05	0.000352	CbGpPWpGaD
Gabapentin—Nausea—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000114	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—AGT—type 2 diabetes mellitus	2.92e-05	0.000351	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.89e-05	0.000348	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.88e-05	0.000347	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.88e-05	0.000346	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CALM1—type 2 diabetes mellitus	2.87e-05	0.000345	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOE—type 2 diabetes mellitus	2.86e-05	0.000344	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.83e-05	0.000341	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOA1—type 2 diabetes mellitus	2.83e-05	0.00034	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.82e-05	0.000339	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.82e-05	0.000339	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.79e-05	0.000335	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.71e-05	0.000326	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.62e-05	0.000316	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.61e-05	0.000314	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.58e-05	0.00031	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GCG—type 2 diabetes mellitus	2.58e-05	0.00031	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.54e-05	0.000305	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.53e-05	0.000304	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARG—type 2 diabetes mellitus	2.49e-05	0.000299	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—INS—type 2 diabetes mellitus	2.44e-05	0.000294	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.41e-05	0.00029	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.37e-05	0.000285	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.37e-05	0.000285	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.24e-05	0.00027	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALB—type 2 diabetes mellitus	2.24e-05	0.000269	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.22e-05	0.000267	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AVP—type 2 diabetes mellitus	2.19e-05	0.000264	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.19e-05	0.000264	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.18e-05	0.000263	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.17e-05	0.000261	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.15e-05	0.000259	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NOS3—type 2 diabetes mellitus	2.14e-05	0.000258	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.14e-05	0.000258	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOB—type 2 diabetes mellitus	2.12e-05	0.000255	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.11e-05	0.000254	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.09e-05	0.000251	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LPL—type 2 diabetes mellitus	2.02e-05	0.000243	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.98e-05	0.000238	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—type 2 diabetes mellitus	1.96e-05	0.000236	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.9e-05	0.000228	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.87e-05	0.000224	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—C3—type 2 diabetes mellitus	1.82e-05	0.000219	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.74e-05	0.000209	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.73e-05	0.000208	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.73e-05	0.000208	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.7e-05	0.000205	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.7e-05	0.000204	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.7e-05	0.000204	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.68e-05	0.000202	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—type 2 diabetes mellitus	1.63e-05	0.000195	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.6e-05	0.000192	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.51e-05	0.000182	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—INS—type 2 diabetes mellitus	1.45e-05	0.000174	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.43e-05	0.000171	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.4e-05	0.000169	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.4e-05	0.000168	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.4e-05	0.000168	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.33e-05	0.00016	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.27e-05	0.000153	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.27e-05	0.000153	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.2e-05	0.000144	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.09e-05	0.000131	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.08e-05	0.00013	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.07e-05	0.000129	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.02e-05	0.000123	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.01e-05	0.000121	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.89e-06	0.000119	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—type 2 diabetes mellitus	9.85e-06	0.000118	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SRC—type 2 diabetes mellitus	9.4e-06	0.000113	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.16e-06	0.00011	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.41e-06	0.000101	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.24e-06	9.91e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—type 2 diabetes mellitus	6.33e-06	7.62e-05	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.84e-06	7.03e-05	CbGpPWpGaD
